1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. INTELLIA THERAPEUTICS INC
Intellia Therapeutics Inc XNAS: NTLA

Intellia Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a rev...

Read More
12.33 -0.17 (-1.36%)
54.80% Fall from 52W High
4.4M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Intellia Therapeutics Inc is on 08 Aug 2025 for the purpose of Intellia Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
14.2 / 100
Momentum Score
Technically Neutral
54.6 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
37
1Yr Price target upside is 201%
27 analysts

15

S

15

W

1

O

2

T

SWOT Analysis

Intellia Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..